| Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats A Armario, A Gavaldà, J Martí Psychoneuroendocrinology 20 (8), 879-890, 1995 | 279 | 1995 |
| Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate A Armario, A Gavaldà, O Martí European journal of pharmacology 158 (3), 207-212, 1988 | 190 | 1988 |
| Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile A Gavalda, M Miralpeix, I Ramos, R Otal, C Carreno, M Vinals, ... Journal of Pharmacology and Experimental Therapeutics 331 (2), 740-751, 2009 | 154 | 2009 |
| Direct evidence for chronic stress-induced facilitation of the adrenocorticotropin response to a novel acute stressor O Marti, A Gavaldà, F Gómez, A Armario Neuroendocrinology 60 (1), 1-7, 1994 | 140 | 1994 |
| Effect of regularity of exposure to chronic immobilization stress on the circadian pattern of pituitary adrenal hormones, growth hormone, and thyroid stimulating hormone in the … O Martí, A Gavaldà, T Jolín, A Armario Psychoneuroendocrinology 18 (1), 67-77, 1993 | 130 | 1993 |
| PDE4 inhibitors: a review of current developments (2005–2009) L Pagès, A Gavaldà, MD Lehner Expert opinion on therapeutic patents 19 (11), 1501-1519, 2009 | 119 | 2009 |
| Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites S Sentellas, I Ramos, J Albertí, M Salvà, F Antón, M Miralpeix, J Beleta, ... European Journal of Pharmaceutical Sciences 39 (5), 283-290, 2010 | 102 | 2010 |
| Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi M Cazzola, L Calzetta, CP Page, P Rogliani, F Facciolo, A Gavaldà, ... European Journal of Pharmacology 745, 135-143, 2014 | 97 | 2014 |
| The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D F Mori, S Pérez-Torres, R De Caro, A Porzionato, V Macchi, J Beleta, ... Journal of chemical neuroanatomy 40 (1), 36-42, 2010 | 95 | 2010 |
| Discovery of Novel Quaternary Ammonium Derivatives of (3R)-Quinuclidinol Esters as Potent and Long-Acting Muscarinic Antagonists with Potential for Minimal Systemic … M Prat, D Fernández, MA Buil, MI Crespo, G Casals, M Ferrer, L Tort, ... Journal of medicinal chemistry 52 (16), 5076-5092, 2009 | 91 | 2009 |
| Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways J Cortijo, M Mata, J Milara, E Donet, A Gavaldà, M Miralpeix, EJ Morcillo European Respiratory Journal 37 (2), 244-254, 2011 | 87 | 2011 |
| Aclidinium inhibits human lung fibroblast to myofibroblast transition J Milara, A Serrano, T Peiró, A Gavaldà, M Miralpeix, EJ Morcillo, J Cortijo Thorax 67 (3), 229-237, 2012 | 75 | 2012 |
| Inhibition of corticosteroid-binding globulin caused by a severe stressor is apparently mediated by the adrenal but not by glucocorticoid receptors O Martí, M Martín, A Gavaldà, M Giralt, J Hidalgo, BRS Hsu, RW Kuhn, ... Endocrine 6, 159-164, 1997 | 74 | 1997 |
| Selective sphingosine 1-phosphate receptor 1 agonist is protective against ischemia/reperfusion in mice VH Brait, G Tarrasón, A Gavaldà, N Godessart, AM Planas Stroke 47 (12), 3053-3056, 2016 | 67 | 2016 |
| Phosphodiesterase-4 inhibitors: a review of current developments (2010–2012) A Gavaldà, RS Roberts Expert opinion on therapeutic patents 23 (8), 997-1016, 2013 | 62 | 2013 |
| Pharmacological characterization of abediterol, a novel inhaled β2-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models M Aparici, M Gomez-Angelats, D Vilella, R Otal, C Carcasona, M Vinals, ... Journal of Pharmacology and Experimental Therapeutics 342 (2), 497-509, 2012 | 58 | 2012 |
| The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide A Gavalda, I Ramos, C Carcasona, E Calama, R Otal, JL Montero, ... Pulmonary pharmacology & therapeutics 28 (2), 114-121, 2014 | 54 | 2014 |
| Acute stress attenuates but does not abolish circadian rhythmicity of serum thyrotrophin and growth hormone in the rat O Martí, A Gavaldà, T John, A Armario European journal of endocrinology 135 (6), 703-708, 1996 | 51 | 1996 |
| Aclidinium inhibits cigarette smoke-induced lung fibroblast-to-myofibroblast transition J Milara, A Serrano, T Peiró, E Artigues, A Gavaldà, M Miralpeix, ... European Respiratory Journal 41 (6), 1264-1274, 2013 | 49 | 2013 |
| Synthesis and Biological Activity of Pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 Inhibitors J Taltavull, J Serrat, J Gracia, A Gavalda, M Andrés, M Córdoba, ... Journal of medicinal chemistry 53 (19), 6912-6922, 2010 | 47 | 2010 |
